Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

OBJECTIVE— Fibroblast growth factor 21 (FGF21) is a metabolic regulator with multiple beneficial effects on glucose homeostasis and insulin sensitivity in animal models. This study aimed to investigate the relationship between its serum levels and various cardiometabolic parameters in humans. RESEAR...

全面介紹

Saved in:
書目詳細資料
Main Authors: Xinmei Zhang, Dennis C.Y. Yeung, Michal Karpíšek, David Stejskal, Zhiguang Zhou, Feng Liu, Rachel L.C. Wong, Wing‐Sun Chow, Annette W.K. Tso, Karen S.L. Lam, Aimin Xu
格式: Artigo
語言:英语
出版: 2008
在線閱讀:https://doi.org/10.2337/db07-1476
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!